2nd October 2025

Medicalisation of female genital mutilation/cutting in South and South East Asia

The policy brief is the first multi-country analysis focused on the medicalisation of FGM/C across South and South East Asia, where healthcare professionals – including doctors, nurses, and midwives – are increasingly performing FGM/C in clinical or semi-clinical settings.

Developed by Equality Now, ARROW, Orchid Project, the Royal College of Obstetricians and Gynaecologists (RCOG), and the Asia Network to End FGM/C, the brief highlights how medicalisation is normalising a harmful practice under the guise of safety and hygiene.

It provides compelling evidence, legal and policy analysis, and clear recommendations to governments, health systems, and international actors to help end this growing trend – and ensure that no girl is harmed in the name of medicine.

What’s inside the report?

  • An overview of available data from eight Asian countries where medicalisation has been documented, with Singapore, Malaysia, and Indonesia showing the highest rates.
  • Examples showing how FGM/C is being offered as part of birth packages or openly advertised in clinics and hospitals.
  • Country-specific analysis of laws, circulars, and policy gaps – with Indonesia as the only country with a legal ban (and only for children under five).
  • Insights into why health professionals in Asia perform FGM/C – often based on community pressure, cultural beliefs, or perceived harm reduction, despite no formal training.
  • Recommendations for national governments, health ministries, professional councils, and UN agencies to act urgently.

Who’s it for?

  • Health ministries and medical professional bodies across Asia
  • Regional and national policymakers
  • UN agencies and global sexual and reproductive health and rights (SRHR) actors
  • Obstetricians, gynaecologists, midwives, and allied healthcare professionals
  • Civil society and advocacy organisations
  • Legal and public health researchers working on FGM/C and gender-based violence

Key findings

  • Medicalised FGM/C is increasing across Asia – especially in urban areas and among younger girls.
  • Healthcare providers from practising communities often perform FGM/C without formal training, driven by cultural, religious, or perceived hygienic justifications.
  • Standardisation is rising, with FGM/C included in postnatal or infant care packages in some countries.
  • There is no evidence of harm reduction. In fact, some health workers perform more severe forms (such as Type 1a) using anaesthetics and anatomical knowledge.
  • Legal and policy protections are weak or non-existent. Only a few countries have circulars banning the practice by medical staff, and most lack enforcement.
  • There is hope. Some midwives in Indonesia have begun refusing to perform FGM/C, offering non-invasive care instead – showing that change is possible.

Explore more resources

1

2

3

The time is now: End female genital mutilation/cutting, an urgent need for global response 2025

This is a comprehensive update to the original 2020 edition, reflecting the most recent global data on female genital mutilation/cutting (FGM/C).

Reporting on female genital mutilation – Global edition

This third edition of Equality Now’s toolkit was developed with support from Wallace Global Fund to support media professionals in their efforts to report on FGM.

Opposing the conflation of female genital mutilation and gender-affirming care in the US

This policy brief warns against conflating female genital mutilation with gender-affirming care in the U.S., highlighting the legal, medical, and human rights risks of misrepresentation and urging rights-based, accurate policymaking.

Newsletter Sign-up

Make a donation

I want to donate